These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 24793444)

  • 21. Statin intolerance - a question of definition.
    Algharably EA; Filler I; Rosenfeld S; Grabowski K; Kreutz R
    Expert Opin Drug Saf; 2017 Jan; 16(1):55-63. PubMed ID: 27645111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statins, cardiovascular disease, and drug safety.
    Gotto AM
    Am J Cardiol; 2006 Apr; 97(8A):3C-5C. PubMed ID: 16581326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expert opinion: the therapeutic challenges faced by statin intolerance.
    Patel J; Martin SS; Banach M
    Expert Opin Pharmacother; 2016 Aug; 17(11):1497-507. PubMed ID: 27254275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose statin therapy: benefits and safety in aggressive lipid lowering.
    Toth PP; Davidson MH
    J Fam Pract; 2008 May; 57(5 Suppl High-Dose):S29-36. PubMed ID: 18662521
    [No Abstract]   [Full Text] [Related]  

  • 25. Safety of statin therapy in patients with preexisting liver disease.
    Onofrei MD; Butler KL; Fuke DC; Miller HB
    Pharmacotherapy; 2008 Apr; 28(4):522-9. PubMed ID: 18363535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An assessment of statin safety.
    McKenney JM
    Am J Manag Care; 2006 Oct; 12(11 Suppl):S310-7. PubMed ID: 17042673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular disease and statin drugs.
    Campbell AW
    Altern Ther Health Med; 2014; 20(5):8-9. PubMed ID: 25141364
    [No Abstract]   [Full Text] [Related]  

  • 28. Management of statin-intolerant patient.
    Arca M; Pigna G; Favoccia C
    Panminerva Med; 2012 Jun; 54(2):105-18. PubMed ID: 22525565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Patients with Statin Intolerance in a Managed Care Plan: A Comparison of 2 Claims-Based Algorithms.
    Bellows BK; Sainski-Nguyen AM; Olsen CJ; Boklage SH; Charland S; Mitchell MP; Brixner DI
    J Manag Care Spec Pharm; 2017 Sep; 23(9):926-934. PubMed ID: 28854079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dyslipidemia: management using optimal lipid-lowering therapy.
    Ito MK
    Ann Pharmacother; 2012 Oct; 46(10):1368-81. PubMed ID: 23032652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Symptomatic myositis-myalgia in hypercholesterolemic statin-treated patients with concurrent vitamin D deficiency leading to statin intolerance may reflect a reversible interaction between vitamin D deficiency and statins on skeletal muscle.
    Glueck CJ; Abuchaibe C; Wang P
    Med Hypotheses; 2011 Oct; 77(4):658-61. PubMed ID: 21802861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient.
    Ong HT
    QJM; 2005 Aug; 98(8):599-614. PubMed ID: 16006501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statin-induced myopathy: a review and update.
    Abd TT; Jacobson TA
    Expert Opin Drug Saf; 2011 May; 10(3):373-87. PubMed ID: 21342078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy.
    Fazio S
    Clin Ther; 2008 Feb; 30(2):294-306. PubMed ID: 18343268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are statins protective or harmful to cognitive function?
    Mospan CM
    JAAPA; 2016 Jan; 29(1):11-2. PubMed ID: 26704648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials.
    Mills EJ; Wu P; Chong G; Ghement I; Singh S; Akl EA; Eyawo O; Guyatt G; Berwanger O; Briel M
    QJM; 2011 Feb; 104(2):109-24. PubMed ID: 20934984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statin drugs: reducing cardiovascular risk in older adults.
    McLain K; Edlund BJ
    J Gerontol Nurs; 2012 Oct; 38(10):9-13. PubMed ID: 22998096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenomics of lipid-lowering therapies.
    Hu M; Tomlinson B
    Pharmacogenomics; 2013 Jun; 14(8):981-95. PubMed ID: 23746191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force.
    McKenney JM; Davidson MH; Jacobson TA; Guyton JR;
    Am J Cardiol; 2006 Apr; 97(8A):89C-94C. PubMed ID: 16581336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statin therapy in patients with type 2 diabetes.
    Lo V; Noviasky J; Nashelsky J
    Am Fam Physician; 2005 Sep; 72(5):866-8. PubMed ID: 16156346
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.